|
|
Volumn 128, Issue 6, 2002, Pages 313-318
|
|
Phase I clinical and pharmacokinetic study of combination chemotherapy with topotecan and ifosfamide in patients with progressive or relapsed solid tumors
a
|
|
Author keywords
Chemotherapy; Ifosfamide; Refractory cancer; Solid tumor; Topotecan
|
|
Indexed keywords
BLEOMYCIN;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
GEMCITABINE;
IFOSFAMIDE;
IRINOTECAN;
MESNA;
METHOTREXATE;
MITOMYCIN C;
OCTREOTIDE;
OXALIPLATIN;
PACLITAXEL;
RALTITREXED;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
TOPOTECAN;
VINCRISTINE;
ADULT;
AGED;
ALOPECIA;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER REGRESSION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG SCREENING;
FEBRILE NEUTROPENIA;
FEMALE;
HUMAN;
LIVER TOXICITY;
MALE;
MAXIMUM TOLERATED DOSE;
NEPHROTOXICITY;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
SOLID TUMOR;
TREATMENT PLANNING;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AREA UNDER CURVE;
DISEASE PROGRESSION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HALF-LIFE;
HUMANS;
IFOSFAMIDE;
MALE;
METABOLIC CLEARANCE RATE;
MIDDLE AGED;
NEOPLASMS;
RECURRENCE;
TOPOTECAN;
|
|
EID: 0036265191
PISSN: 01715216
EISSN: None
Source Type: Journal
DOI: 10.1007/s00432-002-0337-2 Document Type: Article |
|
Times cited : (6)
|
|
References (16)
|
